Sunday, 2 November 2008

Study Shows ENBREL(R) (etanercept) More Effective Than A DMARD In The Treatment Of Symptoms Of Ankylosing Spondylitis Patients

New safety and efficacy data for active ankylosing spondylitis (AS) patients treated with ENBREL(R) (etanercept) were presented at the American College of Rheumatology (ACR) Scientific Meeting, 24-29 October, in San Francisco, CA: (1),(2) - As discussed in an oral pr

No comments: